The anthelmintic efficacy of the drug Expresstabs in helminthiasis of dogs

Abstract

The purpose of the research is to study the  effectiveness  of  the  drug  ExpressTabs tested on dogs infected with helminths. The drug  contains  spinosad,  praziquantel  and moxidectin as active ingredients. Animals of mixed  breeds  of  both  sexes  aged  from  7 months to 2 years were selected for the experiments. Experimental and control groups of dogs with toxocariasis, toxascariasis and dipylidiasis  were  formed.  ExpressTabs was administered  to  dogs  individually,  once, orally in a mixture with food or immediately after feeding (on  the  root  of  the  tongue or with a treat) in a minimum dose of 30 mg of spinosad, 0.2 mg of moxidectin and 5 mg of praziquantel per 1 kg of animal weight. Animals  in  the  control  groups  were  not  given tablets. A control examination in the case of dipylidiasis  was  carried  out  on  the  second day then if the animal continued to remain in the  hospital  once  a  week.  For  toxocariasis and toxascariasis fecal examination was carried out on day 7 then on days 14, 21 and 28. The drug ExpressTabs showed high (100%) effectiveness  in  the  treatment  of dogs with toxocariasis,  toxaccariasis  and  dipylidiasis. In one animal re-infection with toxocariasis was  observed  because  helminth  eggs  were again  detected  on  day  28  in  the  control study. Taking into account the development cycle  of  parasites  it  is  obvious  that  re-infection occurred no later than a week after the  experimental  deworming  with  ExpressTabs. At recommended doses the drug did not cause unwanted side effects.